Study of the oral FLT3/AXL inhibitor gilteritinib for AML to move forwards
Exploring combinatorial approaches in acute myeloid leukemia (AML) treatment
The importance of multiple myeloma foundations and a patient story
Paul Richardson et al.
Upcoming results from clinical trials for treating relapsed, low grade lymphoma
Immunotherapies for the treatment of AML